Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Frank E. Collins currently holds 60,262 shares of PharMerica CORP (PMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank E. Collins has been a net seller of PMC stock. They have purchased $0 and sold $2.5M worth of shares.
Frank E. Collins's most recent insider trade was on Dec 7, 2017, when they sold 60,262 shares at $29.25 per share.
Frank E. Collins serves as Executive at PharMerica CORP (PMC). They have executed 31 insider transactions totaling $2.5M over their tenure at the company.
Frank E. Collins holds the position of Executive at PharMerica CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Frank E. Collins has shown a selling trading pattern, with $0 in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Frank E. Collins was on Feb 25, 2008, when they sold $6.3M worth of SIE shares. This transaction involved 144,223 shares at $43.50 per share.
Frank E. Collins currently owns 60,262 shares of PharMerica CORP (PMC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Frank E. Collins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Frank E. Collins has 31 Form 4 filings on record as an insider at PharMerica CORP.
Set alerts for Frank E. Collins and 40,000+ other insiders.